OpenVSafe by OpenVAERS
Search V-safe

LFN-93824-35013

2 vaccinations 6 coded responses 22 check-ins 5 free-text entries 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
462 / IN
Registered
2022-06-28
Relationship
Child or adolescent in my care
Guardian
7S8-32289-32885
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-28
    Registered in v-safe
  2. 2022-06-28
    Dose 1 — Moderna
  3. 2022-06-28
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-30
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness, Irritability/crying, Loss of appetite
    Under 3 check-in
  6. 2022-07-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-03
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Loss of appetite
    Under 3 check-in
  8. 2022-07-04
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-05
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-12
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-07-19
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-07-26
    Survey response — day 28, dose 1, under 3
    MedDRA: Cough, Decreased appetite, Fatigue, Irritability, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair
    Free text: Runny nose, congestion, mild cough, fatigue, irritability, loss of appetite.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-08-02
    Dose 2 — Moderna
  14. 2022-08-02
    Survey response — day 35, dose 1, under 3
    MedDRA: Upper respiratory tract infection — Feeling: Fair
    Free text: Upper respiratory infection.
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-08-04
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetite
    Under 3 check-in
  16. 2022-08-07
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-08-08
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-08-09
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-08-16
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2022-08-23
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-08-30
    Survey response — day 28, dose 2, under 3
    MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Good
    Free text: Runny nose, sneezing, mild cough.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-09-06
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-09-13
    Survey response — day 42, dose 2, under 3
    MedDRA: Cough — Feeling: Fair
    Free text: Cough
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-11-01
    Survey response — 3 months, dose 2, under 3
    MedDRA: Gastrointestinal disorder — Feeling: Good · Be unable to work or attend school
    Free text: GI illness.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2023-01-31
    Survey response — 6 months, dose 2, under 3
    MedDRA: Upper respiratory tract infection — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-06-28Moderna No
22022-08-02Moderna No

Free text

Release 12 (Under 3) — day 28, dose 1, under 3

2022-07-26

Symptoms: Runny nose, congestion, mild cough, fatigue, irritability, loss of appetite.

Release 12 (Under 3) — day 35, dose 1, under 3

2022-08-02

Symptoms: Upper respiratory infection.

Release 12 (Under 3) — day 28, dose 2, under 3

2022-08-30

Symptoms: Runny nose, sneezing, mild cough.

Release 12 (Under 3) — day 42, dose 2, under 3

2022-09-13

Symptoms: Cough

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-11-01

Symptoms: GI illness.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDecreased appetite · · ✓
SDFatigue · · ✓
SDGastrointestinal disorder · · ✓
SDIrritability · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDSneezing · · ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…